Effects of Different Types of Exercise on BDNF and Cognitive Performance (Exercise-BDNF)

NCT07137611 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-01-30

No results posted yet for this study

Summary

Purpose The purpose of this study is to determine the acute effects of different exercise intensities (low, moderate, high) on brain-derived neurotrophic factor (BDNF) levels, trail making test performance, and perceived sensation scale.

Method

This randomized crossover controlled trial aimes to examine the acute effects of four experimental conditions-high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), low-intensity continuous training (LICT), and a resting control (CTRL)-on cognitive performance (via the Stroop test, targeting executive function) and associated neurochemical responses (e.g., serum BDNF and blood lactate levels) in healthy young adults aged 18-25 years.

All participants will complete the four conditions in a randomized and counterbalanced manner. To ensure balanced exposure, they were assigned to one of four groups (n = 3 per group), each following a distinct condition order based on a Latin square design. This approach guaranteed that each session occurred equally across time points (sessions 1-4) and that the order minimized sequence effects by rotating the position of each condition relative to the others.

To control for potential carryover-particularly from elevated neurochemical responses following intense exercise (BDNF increases reported -no two high-intensity sessions will be scheduled consecutively. Where possible, higher and lower intensity protocols will be alternated. Furthermore, a seven-day interval separated each session to reduce residual physiological or cognitive effects.

The trial protocol was developed in line with CONSORT and SPIRIT guidelines, including relevant extensions for within-subject designs and non-pharmacological interventions. Participants were blinded to the study hypothesis (Pandis et al., 2017; Hopewell et al., 2025).

All exercise sessions will be conducted under supervision of a certified strength and conditioning coach to ensure consistency and adherence to protocol. in the morning (09:00-11:00) on a track and field pitch to control for chronobiological variation. Participants were instructed to avoid strenuous activity for 48 hours prior, abstain from alcohol and caffeine for 24 hours, and obtain at least 7-8 hours of sleep before each session. Dietary habits and general lifestyle were to remain unchanged throughout the study.

During the first visit, participants' body weight and body fat percentage were assessed using bioelectrical impedance analysis. Resting heart rate was then recorded, followed by administration of the Yo-Yo Intermittent Recovery Test Level 1 to determine maximal aerobic speed, aerobic capacity, and peak heart rate.

In the following four visits, each participant completed all experimental conditions. Each exercise session will begin with a standardized 10-minute warm-up, including light jogging, dynamic stretching, and movement preparation drills.

All exercise sessions were conducted on a standard track and field facility and lasted 40 minutes in total, consisting of a 10-minute standardized warm-up, 24 minutes of exercise, and a 5-minute recovery period. The exercise component was individually prescribed based on each participant's maximal aerobic speed, determined from the Yo-Yo Intermittent Recovery Test Level 1. All running distances were calculated individually using time × speed formulas based on each participant's maximal aerobic speed, ensuring workload equivalence across conditions.

* High-Intensity Interval Training: Participants ran at 110% of their MAS for 15-second intervals.
* Moderate-Intensity Continuous Training: Participants ran at a speed corresponding to 70-80% of their MAS.
* Low-Intensity Continuous Training: Participants ran continuously for 24 minutes at 50-60% of their MAS without breaks.
* Control: Participants remained seated at rest for the same duration (40 minutes), under the same environmental conditions and time schedule as the active conditions.

Venous blood samples were collected before and immediately after each session to assess neurochemical markers. Subsequently, cognitive performance was evaluated using the computerized Stroop test to measure executive function. Heart rate was continuously monitored during all exercise conditions using a Polar V800 device. Following each session, psychophysiological responses were assessed using the Rating of Perceived Exertion scale and the Exercise Enjoyment Scale.

Conditions

  • Exercise Training
  • BDNF
  • Cognitive Functions
  • Lactate Blood Increase

Interventions

BEHAVIORAL

Low Exercise

• Low-Intensity Continuous Training (LICT): Participants will run continuously for 24 minutes at 50-60% of their MAS without breaks.

BEHAVIORAL

Moderate-Intensity Exercise

Moderate-Intensity Continuous Training (MICT): Participants will run at a speed corresponding to 70-80% of their MAS. The protocol consists of four 4-minute bouts, separated by 2-minute active recovery periods, during which participants performed light jogging. This pattern totaled 24 minutes of exercise.

BEHAVIORAL

HIIT Exercise

High-Intensity Interval Training (HIIT): Participants will run at 110% of their MAS for 15-second intervals, covering a pre-calculated distance during each bout. After each 15-second sprint, they will rest passively for 15 seconds and returned to their starting point. This will be repeated continuously for 3 minutes, constituting one set. A total of four 3-minute sets will be completed, interspersed with 3-minute passive rest periods, yielding a total exercise time of 24 minutes.

Sponsors & Collaborators

  • Aksaray University Training and Research Hospital

    lead OTHER

Principal Investigators

  • serkan PANCAR, Assistant Professor · Aksaray University /Faculty of Sports Sciences

  • Yakup Zühtü BİRİNCİ, Dr. · Uludag Univesity

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-15
Primary Completion
2025-08-15
Completion
2025-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07137611 on ClinicalTrials.gov